Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients
Article in Cancers (March 2024)
The most recent citing publications are shown below. View all 525 publications that cite this research output on Dimensions.
Article in Cancers (March 2024)
Article in Journal of Behavioral Medicine (February 2024)
Article in Infection (February 2024)